MedTrace Logo

Mindfulness Based Stress Reduction for Intellectually Able Autistic Adults

NCT05244265 · Status: TERMINATED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 140

Last updated 2022-03-08

No results posted yet for this study

Summary

This project evaluates mindfulness based stress-reduction (MBSR), adjusted and manualized for intellectually able autistic adults. MBSR is a skills training program based on further development of cognitive behavioral therapy. The program includes eight weekly group training sessions and one full-day retreat, aiming at stress reduction and improved coping in everyday life, as well as improved mental health.

The aspiration is to make ASD-adjusted MBSR an intervention that is acceptable and accessible to individuals with autism in open clinical care. This includes considering variability in background factors such as age, comorbidity and other personal qualities and preferences.

The aim of the studies is to evaluate (1) the feasibility and (2) effectiveness of MBSR in adults (18 or over) with autism without intellectual disability, in an outpatient clinical habilitation context.

Conditions

  • Treatment Satisfaction
  • Participation Rate, Patient
  • Quality of Life
  • Mental Illness
  • Acceptance Processes
  • Stress, Psychological

Interventions

BEHAVIORAL

Mindfulness-based stress reduction (MBSR)

The 8 week (plus one-day retreat) manualized MBSR program according to the manual (Kabat-Zinn, 1982).

BEHAVIORAL

Treatment as usual (TAU)

Different interventions and support in outpatient and other services.

Sponsors & Collaborators

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
QUADRUPLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2016-01-01
Primary Completion
2021-09-01
Completion
2021-09-01

More Related Trials

Entities

Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05244265 on ClinicalTrials.gov